FFCP PHASE1:Mm9::chr9:110919664..110919671,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=6|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr9:110919664..110919671,-|id=chr9:110919664..110919671,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,3.07e-13,9|ontology_enrichment_disease=DOID:0060100!5.59e-15!3;DOID:4045!5.59e-15!3;DOID:0050686!1.01e-07!6|ontology_enrichment_disease_v019_2=DOID:0060100,4.98e-38,3;DOID:4045,4.98e-38,3;DOID:0050686,1.83e-19,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.07e-13,9;UBERON:0002036,3.07e-13,9;UBERON:0002385,3.07e-13,9;UBERON:0000486,3.07e-13,9;UBERON:0007503,3.07e-13,9;UBERON:0001015,3.07e-13,9;UBERON:0002329,3.07e-13,9;UBERON:0003082,3.07e-13,9;UBERON:0003059,3.07e-13,9;UBERON:0007282,3.07e-13,9;UBERON:0004290,3.07e-13,9;UBERON:0009618,3.07e-13,9;UBERON:0000383,5.47e-12,10;UBERON:0007524,5.80e-11,11;UBERON:0003077,5.80e-11,11;UBERON:0007285,5.80e-11,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.2524550138978,23.440060335714,16.7527598071615,64.7054636834116,14.3439551841274,22.8189865924642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190225626112559,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0.287696137450811,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0.218362563746178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0,0.220591419119515,0|short_description=p@chr9:110919664..110919671,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr9:110919664..110919671,- | |||
|description=CAGE_peak_at_chr9:110919664..110919671,- | |||
|id=chr9:110919664..110919671,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.07e-13,9 | |||
|ontology_enrichment_disease=DOID:0060100!5.59e-15!3;DOID:4045!5.59e-15!3;DOID:0050686!1.01e-07!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,4.98e-38,3;DOID:4045,4.98e-38,3;DOID:0050686,1.83e-19,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.07e-13,9;UBERON:0002036,3.07e-13,9;UBERON:0002385,3.07e-13,9;UBERON:0000486,3.07e-13,9;UBERON:0007503,3.07e-13,9;UBERON:0001015,3.07e-13,9;UBERON:0002329,3.07e-13,9;UBERON:0003082,3.07e-13,9;UBERON:0003059,3.07e-13,9;UBERON:0007282,3.07e-13,9;UBERON:0004290,3.07e-13,9;UBERON:0009618,3.07e-13,9;UBERON:0000383,5.47e-12,10;UBERON:0007524,5.80e-11,11;UBERON:0003077,5.80e-11,11;UBERON:0007285,5.80e-11,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,19.2524550138978,23.440060335714,16.7527598071615,64.7054636834116,14.3439551841274,22.8189865924642,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124406970610093,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.190225626112559,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.25462585178142,0.287696137450811,0,0,1.43768206527355,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0,0,0,0,0,0.139951452323658,0,0,0,0,0,0,0.218362563746178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0574354689556133,0,0,0,0,0,0,0,0,0,0,0.0846146078916765,0,0,0,0,0.118635018124174,0,0,0,0,0,0,0,0,0.220591419119515,0 | |||
|short_description=p@chr9:110919664..110919671,- | |||
}} |
Latest revision as of 15:37, 4 August 2015
Short description: | p@chr9:110919664..110919671, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr9:110919664..110919671, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.07e-13 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.07e-13 | 9 |
striated muscle tissue | 3.07e-13 | 9 |
muscle tissue | 3.07e-13 | 9 |
multilaminar epithelium | 3.07e-13 | 9 |
epithelial vesicle | 3.07e-13 | 9 |
musculature | 3.07e-13 | 9 |
somite | 3.07e-13 | 9 |
myotome | 3.07e-13 | 9 |
presomitic mesoderm | 3.07e-13 | 9 |
presumptive segmental plate | 3.07e-13 | 9 |
dermomyotome | 3.07e-13 | 9 |
trunk paraxial mesoderm | 3.07e-13 | 9 |
musculature of body | 5.47e-12 | 10 |
dense mesenchyme tissue | 5.80e-11 | 11 |
paraxial mesoderm | 5.80e-11 | 11 |
presumptive paraxial mesoderm | 5.80e-11 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 4.98e-38 | 3 |
muscle cancer | 4.98e-38 | 3 |
organ system cancer | 1.83e-19 | 6 |